Loading...
Indian Pharmaceutical Exporter · #12 for Vinblastine · $17.8K export value · DGFT Verified
JPC Global is the #12 Indian exporter of Vinblastine with $17.8K in export value and 5 verified shipments. JPC Global holds a 2.4% market share in Vinblastine exports across 1 countries. The company exports 6 pharmaceutical products worth $286.9K across 4 therapeutic categories.
| VENEZUELA | $48.1K | 6 | 8.8% |
| CHILE | $44.1K | 4 | 8.1% |
| BELARUS | $40.9K | 7 | 7.5% |
| LEBANON | $32.4K | 36 | 5.9% |
| SRI LANKA | $24.0K | 22 | 4.4% |
| KENYA | $21.9K | 44 | 4.0% |
India exports Vinblastine to 96 countries. The top destination is COLOMBIA (13.2%), followed by IRAN and POLAND.
| Buyer | Country | Value | Orders |
|---|---|---|---|
| HIRAD PHRAMED | IRAN | $42.4K | 2 |
| EXP CODE | POLAND | $28.9K | 4 |
| GLORINCOR PHARMACEUTICALS OOO | BELARUS | $28.6K | 4 |
| LABORATORIOS KAMPAR S.A. | CHILE | $26.6K | 3 |
| IMPORT MANAGER CLIENT CODE | LEBANON | $18.1K | 16 |
| ETHIOPIAN PHARMACEUTICALS SUPPLY AG | KENYA | $14.1K | 2 |
| PHARMACEUTICAL DISTOLOZA S.A. | PERU | $11.2K | 3 |
| PEOPLE'S BANK | SRI LANKA | $10.7K | 3 |
India's Vinblastine is purchased by 244 buyers worldwide. The top buyer is HIRAD PHRAMED (IRAN), followed by EXP CODE and GLORINCOR PHARMACEUTICALS OOO.
India exported $558.2K worth of Vinblastine through 573 shipments from 140 suppliers to 96 countries, serving 244 buyers globally. JPC Global contributes $17.8K to this total, accounting for 2.4% of India's Vinblastine exports.
JPC Global's average Vinblastine shipment value is $3.6K per consignment, based on 5 shipments totaling $17.8K.
JPC Global ranks #12 among 140 Indian Vinblastine exporters with a 2.4% market share. The top 3 exporters are NAPROD LIFE SCIENCES PRIVATE LIMITED ($128.5K), SP ACCURE LABS PRIVATE LIMITED ($98.2K), UNITED BIOTECH PRIVATE LIMITED ($47.8K). JPC Global processed 5 shipments to 1 destination countries.
Exporters ranked immediately above and below #12 by export value
| # | Supplier | Export Value | Shipments | Countries | Avg/Shipment |
|---|---|---|---|---|---|
| 10 | NEON LABORATORIES LIMITED | $21.3K | 6 | 4 | $3.5K |
| 11 | KINGS GLOBAL BIOTECH LIMITED | $20.0K | 20 | 2 | $998 |
| 12 | JPC GLOBAL ★ | $17.8K | 5 | 1 | $3.6K |
| 13 | MEDICINEXT PHARMA LLP | $14.7K | 4 | 2 | $3.7K |
| 14 | BRUCK PHARMA PRIVATE LIMITED | $13.0K | 13 | 7 | $1.0K |
JPC Global ranks #12 among 140 Indian Vinblastine exporters. Average shipment value of $3.6K compared to the market average of $4.0K. The closest competitors by value are NEON LABORATORIES LIMITED and KINGS GLOBAL BIOTECH LIMITED.
| Port | Shipments | % Share |
|---|---|---|
| SAHAR AIR | 128 | 22.3% |
| SAHAR AIR CARGO ACC (INBOM4) | 127 | 22.2% |
| Bombay Air | 61 | 10.6% |
| DELHI AIR | 45 | 7.9% |
| DELHI AIR CARGO ACC (INDEL4) | 36 | 6.3% |
| Bombay Air Cargo | 20 | 3.5% |
| AHEMDABAD AIR ACC (INAMD4) | 19 | 3.3% |
| CHENNAI AIR CARGO ACC (INMAA4) | 17 | 3.0% |
JPC Global exports 6 products worth $286.9K. Beyond Vinblastine, top products include Ceftazidime, Antitoxin, Tofacitinib, Ibrutinib, Lomustine. View the complete JPC Global profile for full portfolio analysis.
Latest developments and market context
Detailed market intelligence for Vinblastine — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Verify manufacturer licensing and export certifications with the official agencies above.
Pharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormareAll trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
Global Coverage
Exports to 96+ countries, 244+ buyers
Expert-Reviewed
Analyzed by pharmaceutical trade specialists
Access shipment-level details, pricing data, buyer connections, and competitive analysis for JPC Global's Vinblastine exports. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.
JPC Global
Full Company Profile →
6 products · $286.9K total trade · 4 categories
Access shipment-level records, pricing trends, and buyer contacts for JPC Global.
Request DemoView Pricing →Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports for Vinblastine. For current shipment-level data, contact TransData Nexus.